Qalsody 6.7MG/ML INJ, soln

Ended Awarded Last action

Contract number
36C26024F0506
Awardee
Awarding agency
Obligated
$32,607

Award facts

Contract value 100% obligated
$32,607.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02142, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was made to Biogen U.S. Corporation, a pharmaceutical and biotechnology company, by the Department of Veterans Affairs (VA) for the supply of the drug QALSODY (tofersen). The award is a delivery order placed against Biogen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract, with a ceiling value of $32,607.45 and a period of performance through September 30, 2024. The contract does not have a set-aside designation, indicating it was competed on the open market. Biogen U.S. Corporation has also been awarded two larger indefinite delivery vehicles (IDVs) by the VA National Acquisition Center, including a single-award IDV worth up to $11.39 million for ranibizumab injections and a Blanket Purchase Agreement worth up to $430,578.10 for the drug Spinraza, used to treat spinal muscular atrophy. These IDVs allow the VA to efficiently procure essential pharmaceuticals for veterans across the country.

Quick answers

Who was awarded contract 36C26024F0506?

36C26024F0506 was awarded to Biogen U.s. Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 20, 2024.

How much is contract 36C26024F0506 worth?

The government has obligated $32,607 on 36C26024F0506.

Is contract 36C26024F0506 an order under another contract?

Yes. 36C26024F0506 is a delivery order under 36F79718D0566, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26024F0506 competed?

The extent of competition for 36C26024F0506 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award